Vol 8, No 1 (February 01, 2019): Translational Lung Cancer Research (Stereotactic Body Radiation Therapy for Thoracic Malignancies)

The current and future faces of stereotactic body radiation therapy for thoracic malignancies

Empiric Radiotherapy for Lung Cancer Collaborative Group multiinstitutional evidence-based guidelines for the use of empiric stereotactic body radiation therapy for non-small cell lung cancer without pathologic confirmation

Predictors of pneumonitis-free survival following lung stereotactic body radiation therapy

Optimizing immobilization, margins, and imaging for lung stereotactic body radiation therapy

Medically inoperable stage I non-small cell lung cancer: best practices and long-term outcomes

The evolving toxicity profile of SBRT for lung cancer

Stereotactic body radiotherapy for centrally located stage I nonsmall cell lung cancer

Approaches to stereotactic body radiation therapy for large (≥5 centimeter) non-small cell lung cancer

Stereotactic body radiotherapy as salvage treatment for recurrence of non-small cell lung cancer after prior surgery or radiotherapy

The optimal treatment approaches for stage I small cell lung cancer

Stereotactic ablative body radiation for oligometastatic and oligoprogressive disease

Combining stereotactic body radiation therapy with immunotherapy: current data and future directions